Valuation : Certara, Inc.

Market Cap 1.16B 1B 943M 859M 1.61B 111B 1.61B 11.18B 4.32B 56.42B 4.37B 4.28B 179B P/E 2026 *
-37x
P/E 2027 * 814x
Enterprise Value 1.22B 1.05B 988M 900M 1.68B 116B 1.69B 11.71B 4.53B 59.13B 4.58B 4.48B 187B EV / Sales 2026 *
3.21x
EV / Sales 2027 * 2.93x
Free-Float
67.08%
Yield 2026 *
-
Yield 2027 * -
1 day-1.25%
1 week-7.56%
Current month-9.35%
1 month-6.88%
3 months+45.08%
6 months+8.44%
Current year-14.70%
1 week 7.47
Extreme 7.469
8.05
1 month 7.47
Extreme 7.469
8.88
Current year 4.45
Extreme 4.45
10.2
1 year 4.45
Extreme 4.45
13.88
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 2025-12-31
Director of Finance/CFO 53 2026-07-14
Chief Tech/Sci/R&D Officer - 2025-07-30
Director TitleAgeSince
Chairman 72 2021-11-30
Director/Board Member 68 2012-12-31
Director/Board Member 59 2017-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 Free

Chief Financial Officer

63,532 0.0416%
7/15/26 Other

Chief Financial Officer

191,850 0.1233%
6/1/26 Exercice

General Counsel

57,763 0.0371%
Change 5-day change 1-year change 3-year change Capi.($)
-1.25%-7.56%-26.68%-48.39% 1.16B
+0.09%-3.64%-1.76%+45.46% 3,651B
-1.27%-8.54%+0.12%+957.25% 407B
+0.24%-6.47%-15.77%+17.23% 78.38B
-0.58%+4.60%+61.46%+120.49% 80.89B
+1.02%-4.65%+2.37%-14.04% 75.36B
-0.46%-4.00%-43.75%+183.94% 66.58B
+1.79%-6.73%+4.16%-15.16% 44.99B
+2.39%+0.32%-11.98%+47.76% 39.48B
+2.07%-3.35%+122.94%+248.40% 34.89B
Average +0.44%-2.45%+9.11%+154.29% 447.99B
Weighted average by Cap. +0.04%-1.05%-0.31%+131.26%

Financials

2026 *2027 *
Net sales 380M 327M 308M 281M 525M 36.17B 527M 3.65B 1.41B 18.43B 1.43B 1.4B 58.38B 390M 335M 316M 288M 538M 37.07B 540M 3.74B 1.45B 18.88B 1.46B 1.43B 59.83B
Net income -28.37M -24.41M -22.99M -20.94M -39.19M -2.7B -39.34M -272M -105M -1.38B -107M -104M -4.36B 1.74M 1.5M 1.41M 1.28M 2.4M 165M 2.41M 16.68M 6.45M 84.23M 6.52M 6.38M 267M
Net Debt 55.8M 48.02M 45.21M 41.2M 77.08M 5.31B 77.39M 536M 207M 2.71B 210M 205M 8.57B -23.11M -19.89M -18.73M -17.06M -31.93M -2.2B -32.05M -222M -85.78M -1.12B -86.79M -84.91M -3.55B
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. The Company's proprietary biosimulation platforms are built on biology, chemistry, and pharmacology principles with proprietary mathematical algorithms that model how medicines and diseases behave in the body. It has developed scientifically-based solutions for the collection, standardization, validation, storage, and analysis of the preclinical, clinical and evidence data needed for MIDD. These data solutions are used internally and industry-wide by life sciences companies. The Company applies AI capabilities within established modeling environments and under the supervision of experienced scientists and regulatory experts. Its modeling platforms and curated datasets position it to incorporate emerging AI techniques in a controlled and scientifically rigorous manner.
Employees
1,546
Date Price Change Volume
26-09-10 US$7.515 -1.51% 223,738
26-09-09 US$7.630 -1.42% 1,462,918
26-09-08 US$7.740 -2.52% 2,879,990
26-09-04 US$7.940 -2.34% 1,272,274
26-09-03 US$8.130 -1.81% 2,125,056
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
7.630USD
Average target price
8.335USD
Spread / Average Target
+9.24%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CERT Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!